Flexion Therapeutics to Present Data on Zilretta™ (FX006) at PAINWeek 2017
Sep 07, 2017 11:30 am UTC| Business
BURLINGTON, Mass., Sept. 07, 2017 -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today will present results from an analysis that found patients treated in clinical trials of Zilretta™ (FX006), its lead candidate for the...
McDermott to Present at Pareto Securities’ 24th Oil & Offshore Conference
Sep 07, 2017 11:30 am UTC| Business
HOUSTON, Sept. 07, 2017 -- McDermott International, Inc. (NYSE:MDR) President and Chief Executive Officer David Dickson is scheduled to speak at Pareto Securities’ 24th Oil Offshore Conference in Oslo, Norway on...
IC Group Introduces Evolutionary Loyalty Program
Sep 07, 2017 11:30 am UTC| Business
WINNIPEG, Manitoba, Sept. 07, 2017 -- IC Group is delighted to announce their role in the delivery of a true first in the vision care industry for an established brand: an evolutionary, multi-layered loyalty program...
GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO
Sep 07, 2017 11:30 am UTC| Business
PHILADELPHIA and OXFORD, United Kingdom, Sept. 07, 2017 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that GlaxoSmithKline plc (LSE:GSK) (NYSE:GSK) has...
OpenDrives Partners with ARRI to Demonstrate Accelerated Video Processing Solution at IBC Show
Sep 07, 2017 11:14 am UTC| Business
LOS ANGELES, Sept. 07, 2017 -- OpenDrives today announced that its network-attached, all-flash storage array, Avalanche, will be featured in the ARRI booth (12.F21) at the International Broadcasting Convention (IBC...
Sanofi Alliance Partner Alnylam Gives Update on Fitusiran
Sep 07, 2017 11:04 am UTC| Business
Sanofi Alliance Partner Alnylam Provides Update on Fitusiran Development Program Paris, France - September 7, 2017 - Sanofi alliance partner Alnylam Pharmaceuticals today provided an update on the clinical...
Neuralstem Announces Issuance of Two U.S. Patents
Sep 07, 2017 11:03 am UTC| Business
GERMANTOWN, Md., Sept. 07, 2017 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that it has been awarded two additional patents by...